26 results
8-K
EX-99.1
RPHM
Reneo Pharmaceuticals Inc
10 Oct 23
Regulation FD Disclosure
12:00am
the addressable patient population Key findings from the claims data: ➢ ~3,900 healthcare professionals see ~70% of known patients ➢ Projected prevalence … for for PMM specific for adults with PMM and healthcare the syndromes that are symptoms are retained utilization Spinal Muscular Atrophy (SMA) included within
8-K
EX-99.1
tatopoy54
8 Nov 22
Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:16pm
8-K
EX-99.1
ockqh5
9 Aug 22
Reneo Pharmaceuticals Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
tb1j 6ns4f9
10 May 22
Reneo Pharmaceuticals Reports First Quarter 2022 Financial Results
4:09pm
DEF 14A
yy58zdrlvv86z7u3cg9i
22 Apr 22
Definitive proxy
4:05pm
10-K
2ufol2j3uh293ks53hxq
23 Mar 22
Annual report
4:38pm
8-K
EX-99.1
ub7gdvel0wf
23 Mar 22
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:29pm
8-K
EX-99.1
60509 z3u9gh
12 Nov 21
Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results
9:00am